3,0
18 jun 2008
Voormalige werknemer
Nutley, NJ
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Large company with plenty of funds available for investment or acquisition. Drugs will receive national and international attention - even if that attention is primarily negative in recent years.
Minpunten
Senior management (NAOC) has very little idea of how to actually run a successful sales organization. They get bogged down in the task-oriented society where everyone at Nutley is busy CYA. I can't believe more heads didn't roll after the horrid way they handled Cera in the United States. Plan B? No, we don't need a Plan B. If Actemra hits a few snags (and why wouldn't it?) plan on Roche NA being significantly smaller in 2010 than it was in 2007.